Qurient Co., Ltd. — Investor Relations & Filings
Filings indexed
437
across all filing types
Latest filing
2026-05-21
Share Issue/Capital Cha…
Country
KR
South Korea
Listing
KO
115180
Qurient Co., Ltd. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for unmet medical needs. The company operates on a proprietary 'Network R&D' model, a virtual approach that manages drug development programs from early discovery through clinical phases. Its pipeline includes Adrixetinib for chronic graft-versus-host disease (cGvHD), Telacebec for the treatment of tuberculosis, and a next-generation dual-payload Antibody-Drug Conjugate (ADC) platform for oncology. Qurient advances its portfolio through global clinical trials and strategic collaborations to address critical diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| [기재정정]주식매수선택권행사 | 2026-05-21 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | |
| 주식매수선택권행사 | 2026-04-30 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46718442 | [기재정정]주식매수선택권행사 | 2026-05-21 | Korean | ||
| 46369367 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 39051034 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 39050990 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 39034005 | 주식매수선택권행사 | 2026-04-30 | Korean | ||
| 39033950 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 39033874 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 33241462 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-03 | Korean | ||
| 33117057 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-31 | Korean | ||
| 33117044 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-31 | Korean | ||
| 33046971 | 정기주주총회결과 | 2026-03-26 | Korean | ||
| 33046946 | 주식매수선택권부여에관한신고 | 2026-03-26 | Korean | ||
| 32972911 | 사업보고서 (2025.12) | 2026-03-18 | Korean | ||
| 32972474 | [기재정정]감사보고서제출 (2023 사업연도) | 2026-03-18 | Korean | ||
| 32972443 | [기재정정]감사보고서제출 (2024 사업연도) | 2026-03-18 | Korean | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ACROBIOSYSTEMS CO.,LTD.
Provides recombinant proteins and reagents for life science…
|
301080 | CN | Professional, scientific and te… |
|
ACTINOGEN MEDICAL LIMITED
Developing cortisol-inhibiting therapies for Alzheimer's an…
|
ACW | AU | Professional, scientific and te… |
|
Active Biotech
Biotechnology company developing drugs for oncology and inf…
|
ACTI | SE | Professional, scientific and te… |
|
Adagene Inc.
Clinical-stage biotech developing antibody-based immunother…
|
ADAG | KY | Professional, scientific and te… |
|
ADALTA LIMITED
Clinical-stage biotech developing i-body protein therapeuti…
|
1AD | AU | Professional, scientific and te… |
|
Adaptive Biotechnologies Corp
Decodes the adaptive immune system to develop products for …
|
ADPT | US | Professional, scientific and te… |
|
Adeia Inc.
R&D company that licenses IP for the media, entertainment, …
|
ADEA | US | Professional, scientific and te… |
|
Aditxt, Inc.
Acquires, develops, and deploys health technologies to addr…
|
ADTX | US | Professional, scientific and te… |
|
Advanced Biomed Inc.
Develops microfluidic biochip diagnostic systems for precis…
|
ADVB | US | Professional, scientific and te… |
|
Advanced Proteome Therapeutics Corporation
Develops proprietary technology for chemical modification o…
|
APC.H | CA | Professional, scientific and te… |
Qurient Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15457/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15457 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15457 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15457 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15457}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Qurient Co., Ltd. (id: 15457)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.